Monocytes in the Tumor Microenvironment.


Journal

Annual review of pathology
ISSN: 1553-4014
Titre abrégé: Annu Rev Pathol
Pays: United States
ID NLM: 101275111

Informations de publication

Date de publication:
24 01 2021
Historique:
entrez: 26 1 2021
pubmed: 27 1 2021
medline: 1 4 2021
Statut: ppublish

Résumé

Immunotherapy has revolutionized cancer treatment over the past decade. Nonetheless, prolonged survival is limited to relatively few patients. Cancers enforce a multifaceted immune-suppressive network whose nature is progressively shaped by systemic and local cues during tumor development. Monocytes bridge innate and adaptive immune responses and can affect the tumor microenvironment through various mechanisms that induce immune tolerance, angiogenesis, and increased dissemination of tumor cells. Yet monocytes can also give rise to antitumor effectors and activate antigen-presenting cells. This yin-yang activity relies on the plasticity of monocytes in response to environmental stimuli. In this review, we summarize current knowledge of the ontogeny, heterogeneity, and functions of monocytes and monocyte-derived cells in cancer, pinpointing the main pathways that are important for modeling the immunosuppressive tumor microenvironment.

Identifiants

pubmed: 33497262
doi: 10.1146/annurev-pathmechdis-012418-013058
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

93-122

Auteurs

Stefano Ugel (S)

Section of Immunology, Department of Medicine, University of Verona, Verona 37134, Italy; email: vincenzo.bronte@univr.it.

Stefania Canè (S)

Section of Immunology, Department of Medicine, University of Verona, Verona 37134, Italy; email: vincenzo.bronte@univr.it.

Francesco De Sanctis (F)

Section of Immunology, Department of Medicine, University of Verona, Verona 37134, Italy; email: vincenzo.bronte@univr.it.

Vincenzo Bronte (V)

Section of Immunology, Department of Medicine, University of Verona, Verona 37134, Italy; email: vincenzo.bronte@univr.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH